Sarcomas in the head and neck area are rare diseases with an incidence of under 1% of all head and neck malignant tumours. Osteosarcomas or osteogenic sarcomas consist of neoplastic cells that produce osteoid bone or immature bone. Sarcomas develop more in the mandible than the maxilla. The exact diagnosis of different types of sarcomas is based on the immunohistochemical investigation. These rare tumours are of mesenchymal origin; osteosarcomas and chondrosarcomas are the most common types-Ewing's sarcomas. The use of proton beam radiotherapy in the treatment of osteosarcoma of the maxilla is rarely reported in the literature. We present a case of successfully treated (surgery and proton beam radiotherapy) poorly differentiated highly aggressive osteosarcoma in the ethmoids and maxillary sinus and morbidity after the treatment. We were presented with a case of a 65-year-old man with anaesthesia and palsy of the right face. The stomatology department performed the extraction of a tooth. One month later, the wound was still open. The histology showed an osteogenic sarcoma in the area of the wound. The oncologist and maxillofacial surgeons in a catchment hospital recommended a nonsurgical approach. Hence, we performed a radical maxillectomy and ethmoidectomy, after which we continued with proton bean radiotherapy. The patient is now five years after therapy without signs of sarcoma; however, he has blindness in the right eye and reduced vision in the left eye, as well as gliosis of the brain, vertigo, tinnitus, trismus, and ancylostomiases. Head and neck osteosarcomas treatment is considered a complex multidisciplinary task. It is currently argued that there is no clear therapeutic protocol for successful treatment. Innovations in treatment modalities such as proton beam radiotherapy appear to have potential, although their effects on long-term morbidity and survival outcomes are still undetermined. We present a rare case report of an osteosarcoma of the maxilla involving an innovative, successful treatment procedure combining surgical excision followed by proton beam radiotherapy. This treatment approach may enable maximum tumour control. This protocol has not been adequately described in the world literature for this diagnosis.

3rd Faculty of Medicine Charles University 10000 Prague Czech Republic

Department of Oncology 2nd Faculty of Medicine Charles University University Hospital in Motol 15000 Prague Czech Republic

Department of Otolaryngology Institute of Postgradual Medical Education 10005 Prague Czech Republic

Department of Otorhinolaryngology and Maxillofacial Surgery Military University Hospital 16902 Prague Czech Republic

Department of Pathology Military University Hospital 16902 Prague Czech Republic

Department of Radiology Military University Hospital 16902 Prague Czech Republic

Proton Therapy Center Czech 18000 Prague Czech Republic

See more in PubMed

Soufflet E., Thibaut F. Case report of maxillary osteosarcoma with up-to date review. J. Oral Med. Oral Surg. 2020;26:15. doi: 10.1051/mbcb/2020008. DOI

Enneking W.F., Spanier S.S., Goodman M.A. A system for the surgical staging of musculoskeletal sarcoma. Clin. Orthop. Relat. Res. 1980;153:106–120. doi: 10.1097/00003086-198011000-00013. PubMed DOI

Murphey M.D., Kransdorf M.J. Staging and Classification of Primary Musculoskeletal Bone and Soft-Tissue Tumors According to the 2020 WHO Update, From the AJR Special Series on Cancer Staging. AJR Am. J. Roentgenol. 2021;217:1038–1052. doi: 10.2214/AJR.21.25658. PubMed DOI

ElKordy M.A., ElBaradie T.S., ElSebai H.I., KhairAlla S.M., Amin A.A.E. Osteosarcoma of the jaw: Challenges in the diagnosis and treatment. J. Egypt. Natl. Cancer Inst. 2018;30:7–11. doi: 10.1016/j.jnci.2018.02.001. PubMed DOI

Kuo C., Kent P.M. Young Adult with Osteosarcoma of the Mandible and the Challenge in Management: Review of the Pediatric and Adult Literatures. J. Pediatr. Hematol. Oncol. 2019;41:21–27. doi: 10.1097/MPH.0000000000001332. PubMed DOI

Pires M.D., Martins J.N.R., Dias G.S., Doutel D., Ordinola-Zapata R. Osteosarcoma of the anterior maxilla mimicking a periapical pathology: A case report. Aust. Endod. J. 2021;47:656–663. doi: 10.1111/aej.12491. PubMed DOI

Paparella M.L., Olvi L.G., Brandizzi D., Keszler A., Santini-Araujo E., Cabrini R.L. Osteosarcoma of the jaw: An analysis of a series of 74 cases. Histopathology. 2013;63:551–557. doi: 10.1111/his.12191. PubMed DOI

Chbicheb S., Oujilal A., Wady W. A propos d’un ostéosarcome maxillaire. Méd. Buccale Chir. Buccale. 2007;13:205–212. doi: 10.1051/mbcb/2007021. DOI

Hajji F., Meziane M., Boulaadas M., Benhalima H., Kzadri M. Ostéosarcome des maxillaires: Présentation de deux cas. Méd. Buccale Chir. Buccale. 2011;17:279–282. doi: 10.1051/mbcb/2011140. DOI

Luo Z., Chen W., Shen X., Qin G., Yuan J., Hu B., Lyu J., Wen C., Xu W. Head and neck osteosarcoma: CT and MR imaging features. Dentomaxillofac. Radiol. 2020;49:20190202. doi: 10.1259/dmfr.20190202. PubMed DOI PMC

Chen Y., Shen Q., Gokavarapu S., Lin C., Yahiya, Cao W., Chauhan S., Liu Z., Ji T., Tian Z. Osteosarcoma of head and neck: A retrospective study on prognostic factors from a single institute database. Oral Oncol. 2016;58:1–7. doi: 10.1016/j.oraloncology.2016.04.008. PubMed DOI

Mücke T., Mitchell D.A., Tannapfel A., Wolff K.D., Loeffelbein D.J., Kanatas A. Effect of neoadjuvant treatment in the management of osteosarcomas of the head and neck. J. Cancer Res. Clin. Oncol. 2014;140:127–131. doi: 10.1007/s00432-013-1550-x. PubMed DOI PMC

Laskar S., Kakoti S., Khanna N., Manjali J.J., Mangaj A., Puri A., Gulia A., Nayak P., Pai P., Nair D., et al. Outcomes of osteosarcoma, chondrosarcoma and chordoma treated with image guided-intensity modulated radiation therapy. Radiother. Oncol. 2021;164:216–222. doi: 10.1016/j.radonc.2021.09.018. PubMed DOI

Shim T., Chillakuru Y., Darwish C., Chalif E., Strum D., Benito D.A., Mulcahy C.F., Monfared A. Head and neck osteosarcomas: Analysis of treatment trends and survival outcomes in the United States (2004–2016) Head Neck. 2021;43:3294–3305. doi: 10.1002/hed.26817. PubMed DOI

Brady J.S., Chung S.Y., Marchiano E., Eloy J.A., Baredes S., Park R.C.W. Pediatric head and neck bone sarcomas: An. analysis of 204 cases. Int. J. Pediatr. Otorhinolaryngol. 2017;100:71–76. doi: 10.1016/j.ijporl.2017.06.003. PubMed DOI

Kalavrezos N., Sinha D. Head and neck sarcomas in adulthood: Current trends and evolving management concepts. Br. J. Oral. Maxillofac. Surg. 2020;58:890–897. doi: 10.1016/j.bjoms.2020.05.015. PubMed DOI

Yamaoka M., Akiyama M., Yokokawa Y., Terao Y., Yokoi K., Kato T., Fukushima T., Sakurai H., Ida H. Multidisciplinary therapy including proton beam radiotherapy for a Ewing sarcoma family tumor of maxillary sinus in a 4-year-old girl. Head Neck. 2013;35:E386–E390. doi: 10.1002/hed.23352. PubMed DOI

Boon E., van der Graaf W.T., Gelderblom H., Tesselaar M.E., van Es R.J., Oosting S.F., de Bree R., van Meerten E., Hoeben A., Smeele L.E., et al. Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults. Head Neck. 2017;39:140–146. doi: 10.1002/hed.24556. PubMed DOI PMC

Edge S.B., Compton C.C. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 2010;17:1471–1474. doi: 10.1245/s10434-010-0985-4. PubMed DOI

Brierley J.D., Gospodarowicz M.K., Wittekind C. The TNM Classification of Malignant Tumours. 8th ed. Wiley Blackwell; Oxford, UK: 2017. pp. 36–39.

Han S., Yin X., Xu W., Wang Y., Han W. The Management of Head and Neck Sarcoma. J. Craniofac. Surg. 2020;31:e189–e192. doi: 10.1097/SCS.0000000000006162. PubMed DOI

Seng D., Wu J., Fang Q., Liu F. Prognosis of osteosarcomas in the mandible: 15-year experience of 55 patients. Medicine. 2019;98:e13875. doi: 10.1097/MD.0000000000013875. PubMed DOI PMC

Jung J.H., Huh K.H., Yong T.H., Kang J.H., Kim J.E., Yi W.J., Heo M.S., Lee S.S. Differentiation of osteosarcoma from osteomyelitis using microarchitectural analysis on panoramic radiographs. Sci Rep. 2022;12:12339. doi: 10.1038/s41598-022-16504-9. PubMed DOI PMC

Sain B., Gupta A., Ghosh S., Mondal R.R., Bhattacharya S., Ghose A. Osteosarcoma of the maxilla presenting as a chronic pyogenic abscess: A case report. Int. J. Surg. Case Rep. 2021;87:106425. doi: 10.1016/j.ijscr.2021.106425. PubMed DOI PMC

Gore M.R. Treatment, outcomes, and demographics in sinonasal sarcoma: A systematic review of the literature. BMC Ear Nose Throat Disord. 2018;18:4. doi: 10.1186/s12901-018-0052-5. PubMed DOI PMC

Yao W., Hou J., Liu G., Wu F., Yan Q., Guo L., Wang C. LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway. Mol. Ther. Oncol. 2022;25:189–200. doi: 10.1016/j.omto.2022.03.001. PubMed DOI PMC

Lu J., Kang X., Wang Z., Zhao G., Jiang B. The activity level of follicular helper T cells in the peripheral blood of osteosarcoma patients is associated with poor prognosis. Bioengineered. 2022;13:3751–3759. doi: 10.1080/21655979.2022.2031387. PubMed DOI PMC